Notably, pre-existing transcriptomic and genomic changes were observed in pre-amplified DCIS, indicating that pre-amplified DCIS may create a cellular state primed to gain HER2 amplification for growth advantage. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.